In this issue:
- Tranexamic acid in upper GI bleeding in patients with cirrhosis
- Remission after nucleos(t)ide analogue withdrawal in CHB
- CHB/C, MASLD and risk of cirrhosis and HCC
- The MASH resolution index
- Mortality in CHB treated with tenofovir or entecavir
- Skeletal muscle mass and DAAs in CHC
- CHB baseline viral load and on-treatment HCC risk
- Viral hepatitis testing and treatment in community pharmacies
- HBV knowledge among Australian-born Chinese and Vietnamese
- Continuity of care in CHC
Please login below to download this issue (PDF)